Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC
UBS today upgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to buy (from neutral) and raised its price target to 1900p (from 1610p).
Broker Forecasts...
Thu, 21/11/2019 - 09:50